Positron Emission Tomography (PET) Radiotracer Global Market Report 2025

Description

A positron emission tomography (PET) radiotracer is a radioactive substance used in PET imaging. This radiotracer is administered to a patient via injection, where it binds to specific biological targets, enabling the PET scanner to visualize metabolic activity and diagnose conditions such as cancer or neurological disorders.

The primary types of PET radiotracers include F-18 (Fluorodeoxyglucose 18), Ga-68 (Fibroblast Activation Protein Inhibitor), and others. F-18 (Fluorodeoxyglucose 18) radiotracers are radioactive glucose analogs utilized in PET imaging to evaluate metabolic activity in tissues, particularly for cancer detection. These radiotracers are applied across various medical fields, including oncology, cardiology, gastrointestinal disorders, endocrine issues, and neurology. They are used by end-users such as hospitals and diagnostic centers, among others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The positron emission tomography (PET) radiotracer market research report is one of a series of new reports from The Business Research Company that provides positron emission tomography (PET) radiotracer market statistics, including the positron emission tomography (PET) radiotracer industry's global market size, regional shares, competitors with a positron emission tomography (PET) radiotracer market share, detailed positron emission tomography (PET) radiotracer market segments, market trends and opportunities, and any further data you may need to thrive in the positron emission tomography (PET) radiotracer industry. This positron emission tomography (PET) radiotracer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The positron emission tomography (pet) radiotracer market size has grown strongly in recent years. It will grow from $2.35 billion in 2024 to $2.54 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to the increasing prevalence of infectious diseases, increasing awareness and accessibility, the emergence of novel radiotracers, the rising prevalence of cancer, and the increasing focus on preventive medicine.

The positron emission tomography (pet) radiotracer market size is expected to see strong growth in the next few years. It will grow to $3.61 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to the expansion of applications, regulatory approvals, growth in emerging markets, growing geriatric population, and growing adoption of PET radio scanners. Major trends in the forecast period include the development of micro-pet technology, integration with wearable technology, expansion of theranostics, nano-radiotracers, and blockchain for data security.

The forecast of 9.2% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for cyclotron-produced isotopes and radiopharmaceutical precursors, key imports from Belgium and South Africa, potentially delaying diagnostic imaging procedures.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated rise in infectious diseases is projected to drive the growth of the positron emission tomography (PET) radiotracer market in the coming years. Infectious diseases are illnesses caused by pathogenic microorganisms, including bacteria, viruses, fungi, or parasites. Factors contributing to the increased prevalence of these diseases include climate change, urbanization, globalization, antibiotic resistance, and shifts in human behavior, all of which facilitate the spread of pathogens. PET radiotracers play a crucial role in managing infectious diseases by visualizing metabolic activity and inflammation, which aids in the detection of infections, assessment of treatment responses, and differentiation between infectious and non-infectious conditions, ultimately leading to improved patient outcomes. For example, in February 2024, a report from the UK Health Security Agency, a government agency in the UK, indicated that tuberculosis (TB) cases in England rose by 10.7% in 2023, with 4,850 cases reported compared to 4,380 in 2022. Hence, the growing prevalence of infectious diseases is driving demand for the PET radiotracer market.

Leading companies in the PET radiotracer market are concentrating on developing advanced diagnostic solutions, such as PET imaging agents that improve cancer detection and enhance patient outcomes. A PET imaging agent is a radioactive substance utilized to visualize and measure biological processes in the body during PET scans. For instance, in March 2023, IsoLogic Innovative Radiopharmaceuticals, a Canadian radiopharmaceutical firm, launched Illuccix, also known as the Ga-68 Gozetotide Preparation Kit (PSMA-11), in Canada as a prostate cancer imaging agent aimed at detecting metastatic prostate cancer. This tool is crucial for physicians in identifying metastatic disease and making informed patient management decisions. It is indicated for patients suspected of metastasis who are candidates for initial definitive therapy, as well as for those with suspected recurrence indicated by elevated serum prostate-specific antigen (PSA) levels.

In February 2023, Lantheus Holdings Inc., a U.S.-based developer of diagnostic products, acquired Cerveau Technologies for an undisclosed sum. This acquisition is intended to enhance Lantheus Holdings' imaging pipeline, particularly for Alzheimer's disease diagnostics, by integrating Cerveau's MK-6240, a second-generation PET imaging agent that targets tau tangles in the brain. Cerveau Technologies Inc. is a U.S.-based provider of information and technology specializing in PET radiotracers.

Major companies operating in the positron emission tomography (PET) radiotracer market are Cardinal Health Inc., AstraZeneca PLC, Eli Lilly and Company, Siemens Healthineers AG, GE Healthcare Technologies Inc., Philips Healthcare, Bracco Imaging S.p.A., Neusoft Medical Systems Co Ltd., Lantheus Holdings Inc., Jubilant Pharma Limited, SOFIE Biosciences (SOFIE), Yantai Dongcheng Pharmaceutical Group Co. Ltd., Nordion Inc., RefleXion Medical Inc., Isologic Innovative Radiopharmaceuticals, ABX Advanced Biochemical Compounds GmbH, IBA Radiopharma Solutions S.A., IXICO PLC, ImaginAb Inc., Radiomedix Inc.

North America was the largest region in the positron emission tomography (PET) radiotracer market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the positron emission tomography (PET) radiotracer marker report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the positron emission tomography (PET) radiotracer marker report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The positron emission tomography (PET) radiotracer market consists of sales of FDG (fluorodeoxyglucose), f-dopa (fluorodopa), C-11 methionine, C-11 methionine, F-18 naf (sodium fluoride), and C-11 choline. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Positron Emission Tomography (PET) Radiotracer Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on positron emission tomography (pet) radiotracer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for positron emission tomography (pet) radiotracer ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The positron emission tomography (pet) radiotracer market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Radiotracer Type: F-18 (Fluorodeoxyglucose 18); Ga-68 (Fibroblast Activation Protein Inhibitor); Other Radiotracer Types
2) By Application: Cancer; Heart Disease; Gastrointestinal; Endocrine; Neurological Disorders; Other Applications
3) By End-User: Hospitals; Diagnostic Centers; Other End-Users
Subsegments:
1) By F-18 (Fluorodeoxyglucose 18): F-18 FDG (Fluorodeoxyglucose); F-18 Fluoroethyltyrosine (FET); F-18 Florbetapir (Amyloid PET Imaging)
2) By Ga-68 (Fibroblast Activation Protein Inhibitor): Ga-68 Dotatate (Neuroendocrine Tumor Imaging); Ga-68 PSMA (Prostate-Specific Membrane Antigen Imaging); Ga-68 FAPI (Fibroblast Activation Protein Inhibitor Imaging)
3) By Other Radiotracer Types: C-11 (Carbon-11); N-13 (Nitrogen-13); O-15 (Oxygen-15); Rb-82 (Rubidium-82); I-124 (Iodine-124)
Companies Mentioned: Cardinal Health Inc.; AstraZeneca PLC; Eli Lilly and Company; Siemens Healthineers AG; GE Healthcare Technologies Inc.; Philips Healthcare; Bracco Imaging S.p.A.; Neusoft Medical Systems Co Ltd.; Lantheus Holdings Inc.; Jubilant Pharma Limited; SOFIE Biosciences (SOFIE); Yantai Dongcheng Pharmaceutical Group Co. Ltd.; Nordion Inc.; RefleXion Medical Inc.; Isologic Innovative Radiopharmaceuticals; ABX Advanced Biochemical Compounds GmbH; IBA Radiopharma Solutions S.A.; IXICO PLC; ImaginAb Inc.; Radiomedix Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r32170u

1. Executive Summary

2. Positron Emission Tomography (PET) Radiotracer Market Characteristics

3. Positron Emission Tomography (PET) Radiotracer Market Trends And Strategies

4. Positron Emission Tomography (PET) Radiotracer Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Positron Emission Tomography (PET) Radiotracer Growth Analysis And Strategic Analysis Framework

5.1. Global Positron Emission Tomography (PET) Radiotracer PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Positron Emission Tomography (PET) Radiotracer Market Growth Rate Analysis
5.4. Global Positron Emission Tomography (PET) Radiotracer Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Positron Emission Tomography (PET) Radiotracer Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Positron Emission Tomography (PET) Radiotracer Total Addressable Market (TAM)

6. Positron Emission Tomography (PET) Radiotracer Market Segmentation

6.1. Global Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
F-18 (Fluorodeoxyglucose 18)
Ga-68 (Fibroblast Activation Protein Inhibitor)
Other Radiotracer Types
6.2. Global Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cancer
Heart Disease
Gastrointestinal
Endocrine
Neurological Disorders
Other Applications
6.3. Global Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Diagnostic Centers
Other End-Users
6.4. Global Positron Emission Tomography (PET) Radiotracer Market, Sub-Segmentation Of F-18 (Fluorodeoxyglucose 18), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
F-18 FDG (Fluorodeoxyglucose)
F-18 Fluoroethyltyrosine (FET)
F-18 Florbetapir (Amyloid PET Imaging)
6.5. Global Positron Emission Tomography (PET) Radiotracer Market, Sub-Segmentation Of Ga-68 (Fibroblast Activation Protein Inhibitor), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Ga-68 Dotatate (Neuroendocrine Tumor Imaging)
Ga-68 PSMA (Prostate-Specific Membrane Antigen Imaging)
Ga-68 FAPI (Fibroblast Activation Protein Inhibitor Imaging)
6.6. Global Positron Emission Tomography (PET) Radiotracer Market, Sub-Segmentation Of Other Radiotracer Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
C-11 (Carbon-11)
N-13 (Nitrogen-13)
O-15 (Oxygen-15)
Rb-82 (Rubidium-82)
I-124 (Iodine-124)

7. Positron Emission Tomography (PET) Radiotracer Market Regional And Country Analysis

7.1. Global Positron Emission Tomography (PET) Radiotracer Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Positron Emission Tomography (PET) Radiotracer Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Positron Emission Tomography (PET) Radiotracer Market

8.1. Asia-Pacific Positron Emission Tomography (PET) Radiotracer Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Positron Emission Tomography (PET) Radiotracer Market

9.1. China Positron Emission Tomography (PET) Radiotracer Market Overview
9.2. China Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Positron Emission Tomography (PET) Radiotracer Market

10.1. India Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Positron Emission Tomography (PET) Radiotracer Market

11.1. Japan Positron Emission Tomography (PET) Radiotracer Market Overview
11.2. Japan Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Positron Emission Tomography (PET) Radiotracer Market

12.1. Australia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Positron Emission Tomography (PET) Radiotracer Market

13.1. Indonesia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Positron Emission Tomography (PET) Radiotracer Market

14.1. South Korea Positron Emission Tomography (PET) Radiotracer Market Overview
14.2. South Korea Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Positron Emission Tomography (PET) Radiotracer Market

15.1. Western Europe Positron Emission Tomography (PET) Radiotracer Market Overview
15.2. Western Europe Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Positron Emission Tomography (PET) Radiotracer Market

16.1. UK Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Positron Emission Tomography (PET) Radiotracer Market

17.1. Germany Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Positron Emission Tomography (PET) Radiotracer Market

18.1. France Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Positron Emission Tomography (PET) Radiotracer Market

19.1. Italy Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Positron Emission Tomography (PET) Radiotracer Market

20.1. Spain Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Positron Emission Tomography (PET) Radiotracer Market

21.1. Eastern Europe Positron Emission Tomography (PET) Radiotracer Market Overview
21.2. Eastern Europe Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Positron Emission Tomography (PET) Radiotracer Market

22.1. Russia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Positron Emission Tomography (PET) Radiotracer Market

23.1. North America Positron Emission Tomography (PET) Radiotracer Market Overview
23.2. North America Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Positron Emission Tomography (PET) Radiotracer Market

24.1. USA Positron Emission Tomography (PET) Radiotracer Market Overview
24.2. USA Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Positron Emission Tomography (PET) Radiotracer Market

25.1. Canada Positron Emission Tomography (PET) Radiotracer Market Overview
25.2. Canada Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Positron Emission Tomography (PET) Radiotracer Market

26.1. South America Positron Emission Tomography (PET) Radiotracer Market Overview
26.2. South America Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Positron Emission Tomography (PET) Radiotracer Market

27.1. Brazil Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Positron Emission Tomography (PET) Radiotracer Market

28.1. Middle East Positron Emission Tomography (PET) Radiotracer Market Overview
28.2. Middle East Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Positron Emission Tomography (PET) Radiotracer Market

29.1. Africa Positron Emission Tomography (PET) Radiotracer Market Overview
29.2. Africa Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Positron Emission Tomography (PET) Radiotracer Market Competitive Landscape And Company Profiles

30.1. Positron Emission Tomography (PET) Radiotracer Market Competitive Landscape
30.2. Positron Emission Tomography (PET) Radiotracer Market Company Profiles
- 30.2.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Positron Emission Tomography (PET) Radiotracer Market Other Major And Innovative Companies

31.1. Philips Healthcare
31.2. Bracco Imaging S.p.A.
31.3. Neusoft Medical Systems Co. Ltd.
31.4. Lantheus Holdings Inc.
31.5. Jubilant Pharma Limited
31.6. SOFIE Biosciences (SOFIE)
31.7. Yantai Dongcheng Pharmaceutical Group Co. Ltd.
31.8. Nordion Inc.
31.9. RefleXion Medical Inc.
31.10. Isologic Innovative Radiopharmaceuticals
31.11. ABX Advanced Biochemical Compounds GmbH
31.12. IBA Radiopharma Solutions S.A.
31.13. IXICO PLC
31.14. ImaginAb Inc.
31.15. Radiomedix Inc.

32. Global Positron Emission Tomography (PET) Radiotracer Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Positron Emission Tomography (PET) Radiotracer Market

34. Recent Developments In The Positron Emission Tomography (PET) Radiotracer Market

35. Positron Emission Tomography (PET) Radiotracer Market High Potential Countries, Segments and Strategies

35.1 Positron Emission Tomography (PET) Radiotracer Market In 2029 - Countries Offering Most New Opportunities
35.2 Positron Emission Tomography (PET) Radiotracer Market In 2029 - Segments Offering Most New Opportunities
35.3 Positron Emission Tomography (PET) Radiotracer Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer